Neupogen
Showing 26 - 50 of 379
Relapsed Non Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Mexico City (Rituximab, Carboplatin, Cytarabine
Completed
- Relapsed Non Hodgkin Lymphoma
- Refractory Non-Hodgkin Lymphoma
- Rituximab
- +4 more
-
Mexico City, Azcapotzalco, MexicoHospital Especialidades Centro Medico La Raza
May 15, 2021
Acute Myeloid Leukemia Trial in Duarte (procedure, drug, biological, other, radiation)
Recruiting
- Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Duarte, CaliforniaCity of Hope Medical Center
Jun 8, 2022
Multiple Myeloma Trial in Westwood (Bortezomib, Granulocyte colony-stimulating factor (G-CSF), Mozobil)
Completed
- Multiple Myeloma
- Bortezomib
- +2 more
-
Westwood, KansasThe University of Kansas Medical Center
May 24, 2021
Non-Hodgkin's Lymphoma, Acute Leukemia in Remission, Chronic Myeloid Leukemia Trial in Tampa (drug, radiation, procedure)
Completed
- Non-Hodgkin's Lymphoma
- +7 more
- Fludarabine
- +7 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Sep 14, 2021
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (procedure, drug, biological)
Recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- filgrastim
- +5 more
-
Durham, North Carolina
- +8 more
Dec 17, 2021
Multiple Sclerosis, Relapsing-Remitting Trial in Chicago (Cyclophosphamide, Mesna, rATG)
Terminated
- Multiple Sclerosis, Relapsing-Remitting
- Cyclophosphamide
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Childhood Solid Tumors Trial in Memphis (Talazoparib, Irinotecan, Temozolomide)
Completed
- Childhood Solid Tumors
- Talazoparib
- +4 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Feb 8, 2021
Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)
Recruiting
- Acute Lymphoblastic Leukemia (ALL)
- +7 more
- Cyclophosphamide
- +11 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Oct 8, 2021
Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)
Completed
- Glioblastoma
- Gliosarcoma
- 3-Dimensional Conformal Radiation Therapy
- +10 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 4, 2022
Multiple Myeloma, Non-Hodgkin's Lymphoma Trial in Indianapolis (Meloxicam, Filgrastim)
Completed
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
-
Indianapolis, IndianaIndiana University Melvin and Bren Simon Cancer Center
Feb 2, 2021
Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)
Terminated
- Stiff-Person Syndrome
- Autologous Hematopoietic Stem Cells
- +6 more
-
Chicago, IllinoisNorthwestern University
Jan 6, 2021
Aggressive Non-Hodgkin Lymphoma, ALK-Positive Large B-Cell Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate
Recruiting
- Aggressive Non-Hodgkin Lymphoma
- +8 more
- Polatuzumab Vedotin
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 26, 2023
Fertility Disorders Trial (Granulocyte Colony Stimulated Factor, Human Chorionic Gonadotropins)
Unknown status
- Fertility Disorders
- Granulocyte Colony Stimulated Factor
- Human Chorionic Gonadotropins
- (no location specified)
Oct 23, 2020
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug, biological, radiation)
Recruiting
- Acute Leukemia
- +18 more
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 26, 2022
Leukemia, Lymphoma Trial in Houston (drug, radiation, procedure)
Completed
- Leukemia
- Lymphoma
- Rituximab
- +10 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Jan 6, 2021
Intraocular Retinoblastoma Trial in United States (drug, procedure, biological)
Completed
- Intraocular Retinoblastoma
- liposomal vincristine sulfate
- +5 more
-
Arcadia, California
- +10 more
Jul 12, 2021
Leukemia, Acute Lymphoblastic Leukemia Trial in Houston (Rituximab, Cyclophosphamide (CTX), Doxorubicin)
Completed
- Leukemia
- Acute Lymphoblastic Leukemia
- Rituximab
- +11 more
-
Houston, TexasUT MD Anderson Cancer Center
Dec 1, 2020
Stem Cell Transplantation, Leukemia Trial in Houston (Plerixafor, Filgrastim, Fludarabine)
Completed
- Stem Cell Transplantation
- Leukemia
- Plerixafor
- +5 more
-
Houston, TexasUT MD Anderson Cancer Center
Sep 22, 2020
Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic
Terminated
- Adult Acute Megakaryoblastic Leukemia (M7)
- +15 more
- fludarabine phosphate
- +4 more
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Severe Aplastic Anemia Trial in United States (drug, radiation, procedure)
Completed
- Severe Aplastic Anemia
- Antithymocyte Globulin (ATG)
- +7 more
-
Duarte, California
- +27 more
Jul 21, 2022
Childhood Favorable Prognosis Hodgkin Lymphoma, Childhood Lymphocyte Depletion Hodgkin Lymphoma, Childhood Mixed Cellularity
Completed
- Childhood Favorable Prognosis Hodgkin Lymphoma
- +5 more
- radiation therapy
- +11 more
-
Arcadia, CaliforniaChildren's Oncology Group
Mar 26, 2021
Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,
Terminated
- Acute Biphenotypic Leukemia
- +29 more
- Cyclophosphamide
- +7 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 4, 2023